Type 2 Diabetes Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been diagnosed with type 2 diabetes by a doctor
- People who are between 19 and 65 years of age
- People whose body mass index (BMI) falls between 20 and 35 kg/m² (BMI is a measure based on height and weight)
- People who are managing their diabetes with tablets or other non-insulin oral medications, and are not using insulin
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have a history of gastrointestinal (digestive system) diseases
- People who eat large amounts of nuts, flaxseeds, or sesame seeds (more than one serving per day)
- People who have food allergies or intolerances
- People who have or have had cancer
- People who have kidney failure, liver conditions, other hormonal disorders, or inflammatory conditions
- People who are taking cholesterol-lowering medications
- People who smoke or drink alcohol
- People who are pregnant or breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Primary endpoints
Evaluation of the effect of flaxseed on fasting blood glucose (mg/dL); Evaluation of the effect of flaxseed on HbA1c (%); Evaluation of the effect of flaxseed on total triglyceride (mg/dL); Evaluation of the effect of flaxseed on total cholesterol (mg/dL); Evaluation of the effect of flaxseed on HDL-cholesterol (mg/dL); Evaluation of the effect of flaxseed on LDL-cholesterol (mg/dL); Evaluation of the effect of flaxseed on quality of life
Can't join this trial?
Data last synced from ClinicalTrials.gov: 24 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.